HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gross, C. Articles by Brücke, P. Search for Related Content PubMed PubMed Citation Articles by Gross, C. Articles by Brücke, P.

Ann Thorac Surg 1999;68:919-924
© 1999 The Society of Thoracic Surgeons

---

Original Articles: Cardiovascular

Aortic valve replacement: is the stentless xenograft an alternative to the homograft? midterm results

^a Department of Surgery I and Cardiology, General Hospital Linz, Linz, Austria
^b Department of Statistics, Johannes Kepler-Universität, Linz, Austria

Address reprint requests to Dr Gross, Department of Surgery I, General Hospital Linz, Krankenhausstr 9, 4020 Linz, Austria

Background. This study was performed to assess the midterm clinical results after aortic valve replacement (AVR) with stentless xenograft (SX) compared with cryopreserved aortic or pulmonary homografts (HX).

Methods. In 139 patients (< 60 years) undergoing elective AVR, 59 HX and 80 SX were inserted. All patients were followed clinically and by color flow Doppler echocardiography for 45 ± 12 months (range 31–58 months).

Results. There were 5 in-hospital deaths (3.5%): 4 HX and 1 SX (p = NS). The mean gradient was 6 ± 2 mm Hg in HX versus 13 ± 6 mm Hg in SX (p < 0.001) and remained unchanged during follow-up. Actuarial survival (HX 77%, SX 80%), freedom from endocarditis (HX 91%, SX 99%), freedom from thromboembolic events (HX 98%, SX 90%), and freedom from reoperation (HX 98%, SX 100%) were comparable between groups after 58 months.

Conclusions. Despite slightly higher transvalvular gradients, the stentless aortic valve achieved excellent midterm results, when compared with homografts.

This article has been cited by other articles:

				N. D. Desai and G. T. Christakis Bioprosthetic Aortic Valve Replacement: Stented Pericardial and Porcine Valves Card. Surg. Adult, January 1, 2008; 3(2008): 857 - 894. [Full Text]

				I. Martinovic, M. Everlien, I. Farah, T. Wittlinger, I. Knez, H. Greve, and P. Vogt Midterm Results After Aortic Valve Replacement With a Stentless Bioprosthesis Aortic Valve Ann. Thorac. Surg., July 1, 2005; 80(1): 198 - 203. [Abstract] [Full Text] [PDF]

				E. Erek, Y. K. Yalcinbas, E. Salihoglu, N. Ozturk, S. Arat, A. Sarioglu, U. B. Samanli, and T. Sarioglu Fate of Stentless Bioprostheses on Right Side of the Heart Asian Cardiovasc Thorac Ann, March 1, 2003; 11(1): 58 - 62. [Abstract] [Full Text] [PDF]

				N. D. Desai and G. T. Christakis Stented Mechanical/Bioprosthetic Aortic Valve Replacement Card. Surg. Adult, January 1, 2003; 2(2003): 825 - 856. [Full Text]

				D. B. Doty and J. R. Doty Stentless Aortic Valve Replacement: Bioprostheses Card. Surg. Adult, January 1, 2003; 2(2003): 889 - 898. [Full Text]

				S. Gelsomino, R. Frassani, L. Porreca, G. Morocutti, A. Morelli, and U. Livi Early and midterm results of model 300 CryoLife O'Brien stentless porcine aortic bioprosthesis Ann. Thorac. Surg., May 1, 2001; 71 (2007): S297 - S301. [Abstract] [Full Text] [PDF]

				S. Silberman, N. Shapira, and D. Bitran Comparison between stentless xenografts and homografts Ann. Thorac. Surg., June 1, 2000; 69(6): 1989 - 1989. [Full Text] [PDF]